Position in LCTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,526
-$53,289 QoQ
Shares Held
36,280
-43.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 130 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,834,089 across 147 Biotechnology names. LCTX ranks #85 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | 29,790 | $3,954,026 | |||
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in LCTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,526 | 36,280 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $100,815 | 63,807 | Shares | Defined | 2026-05-14 | |
| 2024-06-30 | $78,454 | 78,454 | Shares | Defined | 2024-08-09 | |
| 2023-03-31 | $26,281 | 17,521 | Shares | Defined | 2023-05-01 | |
| 2022-12-31 | $51,997 | 44,442 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $11,331 | 10,028 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $21,140 | 13,380 | Shares | Defined | 2022-08-09 | |
| 2021-06-30 | $154,273 | 54,131 | Shares | Defined | 2021-09-17 | |
| 2020-09-30 | $37,898 | 40,318 | Shares | Defined | 2020-12-11 | |
| 2020-06-30 | $67,896 | 78,042 | Shares | Defined | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||